<h3>Gainers</h3>
<ul>
<li>Greenwich LifeSciences (NASDAQ:GLSI) stock increased by 25.5% to $25.96 during Monday's regular session. The company's market cap stands at $276.5 million. </li>
<li>Nutriband (NASDAQ:NTRB) stock increased by 19.16% to $5.72. The company's market cap stands at $58.4 million. </li>
<li>Zura Bio (NASDAQ:ZURA) stock rose 16.19% to $5.4. The market value of their outstanding shares is at $302.3 million. </li>
<li>Palisade Bio (NASDAQ:PALI) shares moved upwards by 15.72% to $2.49. The company's market cap stands at $320.7 million. </li>
<li>Prelude Therapeutics (NASDAQ:PRLD) shares increased by 15.13% to $2.82. The market value of their outstanding shares is at $154.0 million. </li>
<li>Strata Skin Sciences (NASDAQ:SSKN) shares moved upwards by 14.22% to $1.41. The market value of their outstanding shares is at $7.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Mereo BioPharma Group (NASDAQ:MREO) shares fell 90.3% to $0.22 during Monday's regular session. The market value of their outstanding shares is at $367.5 million. </li>
<li>Ultragenyx Pharmaceutical (NASDAQ:RARE) shares declined by 44.11% to $19.11. The market value of their outstanding shares is at $3.2 billion. </li>
<li>Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) shares declined by 33.24% to $0.05. </li>
<li>Inovio Pharmaceuticals (NASDAQ:INO) shares decreased by 21.62% to $1.79. The market value of their outstanding shares is at $157.3 million. </li>
<li>Trinity Biotech (NASDAQ:TRIB) shares decreased by 17.99% to $0.82. The market value of their outstanding shares is at $19.1 million. </li>
<li>Cue Biopharma (NASDAQ:CUE) shares declined by 15.8% to $0.27. The market value of their outstanding shares is at $29.6 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TRIB

MREO

In Monday's intraday session, several health care stocks experienced significant movements. Notable gainers included Greenwich LifeSciences (GLSI), up 25.5% to $25.96, and Nutriband (NTRB), rising 19.16% to $5.72. Other gainers were Zura Bio (ZURA), Palisade Bio (PALI), Prelude Therapeutics (PRLD), and Strata Skin Sciences (SSKN). Conversely, Mereo BioPharma Group (MREO) saw a drastic decline of 90.3% to $0.22, while Ultragenyx Pharmaceutical (RARE) fell 44.11% to $19.11. Other losers included Bristol-Myers Squibb (CELGR), Inovio Pharmaceuticals (INO), Trinity Biotech (TRIB), and Cue Biopharma (CUE).

12 Health Care Stocks Moving In Monday's Intraday Session